ESC 365 - Antihypertensive treatment of masked hypertension guided by ambulatory blood pressure monitoring: a double-blind, placebo-controlled trial

ESC Premium Access

Antihypertensive treatment of masked hypertension guided by ambulatory blood pressure monitoring: a double-blind, placebo-controlled trial

Session: Pharmacological management of hypertension

Topic: Pharmacotherapy

Speaker: Doctor D. Zhang (Shanghai, CN)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Dongyan Zhang

Rui Jin Hospital- Shanghai Jiaotong University School of Medicine, Shanghai (China)

0 follower

5 more presentations in this session

Subgroup results from KARDIA-2: impact of demographic and baseline disease characteristics on zilebesiran response in patients with hypertension uncontrolled by a standard oral antihypertensive

Speaker: Doctor M. Saxena (London, GB)

Safety, tolerability and blood pressure lowering of the innovative guanylyl cyclase a-receptor activator MANP in an ethnically diverse resistant hypertension population: a phase 1B clinical trial

Speaker: Professor H. Chen (Rochester, US)

Angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers vs. calcium channel blockers for 12,478 young hypertensive patients under 40 in 10-year follow-up

Speaker: Doctor S. Jo (Anyang-Si- Gyeonggi-Do, KR)

Blood pressure lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of 500 randomised, double-blind placebo-controlled trials

Speaker: Doctor N. Wang (Sydney, AU)

Antihypertensive treatment during pregnancy and maternal and fetal outcomes

Speaker: Professor J. Vaclavik (Ostrava, CZ)

Access the full session

Pharmacological management of hypertension

Speakers: Doctor D. Zhang, Doctor M. Saxena, Professor H. Chen, Doctor S. Jo, Doctor N. Wang...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources